JOURNAL DESCRIPTION

The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.

Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.

Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.

The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.

Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.

The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.

Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.

The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.

Medical Radiology and Radiation Safety. 2026. Vol. 71. № 2

DOI:10.33266/1024-6177-2026-71-2-115-121

Karthik Shunmugavelu1, Evangeline Cynthia Dhinakaran2

Role of Ultrasound in Salivary Gland Tumors: a Systematic Review

1 Medical College Hospital and Research Institute Tambaram Kanchipuram, Tamilnadu, India

2 Sree Balaji Medical College and Hospital, Tamilnadu, India

Contact person: Karthik Shunmugavelu, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

ABSTRACT

Background: Salivary gland tumors (SGTs) are a heterogeneous group of lesions, from benign to extremely malignant neoplasms. Early and correct diagnosis is critical for proper clinical management. Ultrasound (US), being an inexpensive, non-invasive, and readily available imaging technique, has a pivotal role in the initial assessment of SGTs. The last few years have added power to the diagnostic armamentarium of US through elastography and radiomics. This systematic review critically examines existing evidence regarding the diagnostic utility and accuracy of ultrasound to differentiate benign from malignant SGTs.

Material and methods: The review adhered to PRISMA guidelines. Systematic searches of electronic databases – PubMed, Scopus, and Web of Science – were conducted for original research articles published 2012–2025. Included studies compared ultrasound approaches (grayscale US, elastography, and radiomics-based US) for the diagnosis of SGTs, with diagnostic performance reported. Non-original papers, case reports, and non-diagnostic outcome reports were excluded. Data were extracted regarding study design, sample characteristics, ultrasound techniques, and diagnostic accuracy.

Results: Five studies were found based on the inclusion criteria. Grayscale ultrasound yielded high specificity (up to 90 %) but low sensitivity (as low as 38.9 %) for detecting malignant lesions. Elastography, including shear wave elastography (SWE) and real-time elastography (RTE), improved diagnostic sensitivity and specificity (SWE: sensitivity 74 %, specificity 62 %). Radiomics-based ultrasound had the highest reported diagnostic accuracy (90 %), sensitivity (78 %), and specificity (92 %). Ultrasound-guided fine needle aspiration (US-FNA) cytology always possessed superior diagnostic sensitivity (up to 91 %) in all studies. US-FNA cytology was also helpful in distinguishing between SGTs and other inflammatory and autoimmune disorders such as Sjögren’s syndrome.

Discussion: Gray-scale conventional ultrasound still forms a cornerstone of the initial evaluation of salivary gland tumors, but its low sensitivity makes adjunctive techniques necessary. Elastography adds useful information on tissue stiffness and enhances differentiation between benign and malignant lesions. Radiomics and artificial intelligence-based models represent an exciting horizon for objective, automated diagnosis but need clinical validation. US-FNA cytology is still irreplaceable for diagnostic confirmation. Standardization of the imaging protocol and multicenter validation studies involving more patients are required to implement these advances in everyday practice.

Conclusion: Ultrasound, particularly when integrated with advanced techniques such as elastography and radiomics, significantly enhances the non-invasive diagnostic workup of salivary gland tumors. However, ultrasound-guided FNA cytology continues to be the diagnostic gold standard. Future research should focus on large-scale validation, integration of computational tools, and standardized imaging approaches to further improve diagnostic accuracy and patient outcomes.

Keywords: salivary gland tumors, ultrasound, elastography, radiomics, diagnostic accuracy, fine needle aspiration cytology

For citation: Karthik Shunmugavelu, Evangeline Cynthia Dhinakaran. Role of Ultrasound in Salivary Gland Tumors: a Systematic Review. Medical Radiology and Radiation Safety. 2026;71(2):115–121. DOI:10.33266/1024-6177-2026-71-2-115-121

 

 

References

  1. Young A., Okuyemi O.T. Malignant Salivary Gland Tumors. Treasure Island, StatPearls Publishing, 2025 Jan-. URL: https://www.ncbi.nlm.nih.gov/books/NBK563022/.
  2. Ghaderi H., Kruger E., Ahmadvand S., Mohammadi Y., Khademi B., Ghaderi A. Epidemiological Profile of Salivary Gland Tumors in Southern Iranian Population: a Retrospective Study of 405 Cases. J Cancer Epidemiol. 2023 Nov 20;2023:8844535. Doi: 10.1155/2023/8844535. PMID: 38026266; PMCID: PMC10681769.
  3. Keyur Kumar Gulabbhai Patel, Anand Palas, Amit J Asari, Jigar Bachubhai Baria. Histomorphological Spectrum of Salivary Gland Tumors: a Study at Tertiary Care Teaching Hospital of North Gujarat.  Tropical Journal of Pathology and Microbiology. 2018;4;8:560-565. Doi: 10.17511/jopm.2018.i08.03.
  4. Iyer J., Hariharan A., Cao U.M.N., Mai C.T.T., Wang A., Khayambashi P., Nguyen B.H., Safi L., Tran S.D. An Overview on the Histogenesis and Morphogenesis of Salivary Gland Neoplasms and Evolving Diagnostic Approaches. Cancers. 2021;13;15:3910. Doi: 10.3390/cancers13153910.
  5. Wang S., Hossack J.A., Klibanov A.L. From Anatomy to Functional and Molecular Biomarker Imaging and Therapy: Ultrasound is Safe, Ultrafast, Portable, and Inexpensive. Invest Radiol. 2020 Sep;55;9:559-572. Doi: 10.1097/RLI.0000000000000675. PMID: 32776766; PMCID: PMC10290890.
  6. Wu S., Liu G., Chen R., Guan Y. Role of Ultrasound in the Assessment of Benignity and Malignancy of Parotid Masses. Dentomaxillofac Radiol. 2012 Feb;41;2:131-5. Doi: 10.1259/dmfr/60907848. Epub 2011 Nov 24. PMID: 22116132; PMCID: PMC3520365.
  7. Sigrist R.M.S., Liau J., Kaffas A.E., Chammas M.C., Willmann J.K. Ultrasound Elastography: Review of Techniques and Clinical Applications. Theranostics. 2017 Mar 7;7;5:1303-1329. Doi: 10.7150/thno.18650. PMID: 28435467; PMCID: PMC5399595.
  8. Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., Chou R., Glanville J., Grimshaw J.M., Hróbjartsson A., Lalu M.M., Li T., Loder E.W., Mayo-Wilson E., McDonald S., McGuinness L.A., Stewart L.A., Thomas J., Tricco A.C., Welch V.A., Whiting P., Moher D. The PRISMA 2020 Statement: an Updated Guideline for Reporting Systematic Reviews. BMJ. 2021 Mar 29;372:n71. Doi: 10.1136/bmj.n71. PMID: 33782057; PMCID: PMC8005924.
  9. Cheng P.C., Lo W.C., Liao L.J., Chiang H.K. Diagnosis of Salivary Gland Tumors Using Ultrasound Radiomics. Ultrasound Med Biol. 2025 May;51;5:815-822. Doi: 10.1016/j.ultrasmedbio.2025.01.008. Epub 2025 Feb 5. PMID: 39909789.
  10. Cheng P.-C., Lo W.-C., Chang C.-M., Wen M.-H., Cheng P.-W., Liao L.-J. Comparisons among the Ultrasonography Prediction Model, Real-Time and Shear Wave Elastography in the Evaluation of Major Salivary Gland Tumors.  Diagnostics. 2022;12;10:2488. Doi: 10.3390/diagnostics12102488.
  11. El-Rasheedy A.El.I., Abdalla A.M.A.R., Hassanein S.Ah., et al. The Role of Ultrasound in Evaluating Salivary Glands Swellings.  Egypt J Otolaryngol. 2021;37:101. Doi: 10.1186/s43163-021-00165-y.
  12. Krumrey-Langkammerer M., Haas J.P. Salivary Gland Ultrasound in the Diagnostic Workup of Juvenile Sjögren’s Syndrome and Mixed Connective Tissue Disease. Pediatr Rheumatol Online J. 2020 Jun 9;18;1:44. Doi: 10.1186/s12969-020-00437-6. PMID: 32517804; PMCID: PMC7285617.
  13. Joshi A.N., Kamble R.C., Mestry P.J. Ultrasound Characterization of Salivary Lesions. Int J Otorhinolaryngol Clin. 2013;5;4:16-29. Doi: 10.5005/aijoc-5-4-16.

 

 

 PDF (RUS) Full-text article (in Russian)

 

Conflict of interest. The authors declare no conflict of interest.

Financing. The study had no sponsorship.

Contribution. Article was prepared with equal participation of the authors.

Article received: 20.01.2026. Accepted for publication: 25.02.2026.

 

Contact Information

 

46, Zhivopisnaya st., 123098, Moscow, Russia Phone: +7 (499) 190-95-51. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Journal location

Attendance

4006262
Today
Yesterday
This week
Last week
This month
Last month
For all time
853
6045
19894
30856
135967
124261
4006262


Your IP:216.73.217.31